SCHEMBL21020264

SCHEMBL21020264

Cc1ccc(N(C)c2cccc3c2oc2ccccc23)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
AHR P35869 1/20 0.38
ALOX5 P09917 3/20 0.37
PGR P06401 1/20 0.36
RAB9A P51151 1/20 0.36
CASP3 P42574 1/20 0.35
MAOB P27338 2/20 0.35
TNKS O95271 1/20 0.35
PARP1 P09874 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
PARP2 Q9UGN5 1/20 0.35
MAOA P21397 1/20 0.35
ALDH1A1 P00352 3/20 0.34
PPARG P37231 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
MAPT P10636 3/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20172791 0.87 PGR (0.40) LMNAAHRALOX5PGRRAB9A
SCHEMBL23967662 0.86 CYP1A2 (0.38) LMNAAHRALDH1A1MAPTTP53
SCHEMBL20650772 0.85 LMNA (0.39) LMNAAHRALOX5PGRRAB9A
SCHEMBL22059181 0.85 LMNA (0.39) LMNAAHRALOX5RAB9ACASP3
SCHEMBL21020447 0.82 CYP1A2 (0.32) RAB9ANPC1
SCHEMBL17933247 0.81 C5AR1 (0.38) LMNAALOX5PGRRAB9ACASP3
SCHEMBL21021478 0.81 CYP1A2 (0.31)
SCHEMBL21020274 0.80 LMNA (0.33) LMNAMAPTMEN1KMT2A
SCHEMBL21020285 0.80 MEN1 (0.30) LMNAMAPTMEN1KMT2A
SCHEMBL21021455 0.80 MEN1 (0.36) LMNAALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ETV6, ESR1 LMNA 3923/4885AHR 1313/4885ALOX5 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.